Skip to main content
Clinical Trials/NCT03281863
NCT03281863CompletedNot Applicable

Clinical Audit on the Managment of Rheumatic Fever in Assiut University Children Hospital

Assiut University1 site in 1 country100 target enrollmentStarted: October 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
laboratory investigations (ASOt , ESR . CRP)

Study Overview

Brief Summary

clinical audit on the Managment of rheumatic fever in assiut university children hospital.

Detailed Description

Acute rheumatic fever,an auto immune response to Group A streptococcus infection of the upper respiratory tract,may result in carditis.when the inflammation leads to permenant damage of the valves the individual has rheumatic heart disease.

Recurrences of rheumatic fever are likely in the absence of preventive measures and may cause further cardiac valve and muscle damage,leading to heart failure,stroke and premature death.bacterial endocarditis is also a complication.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
5 Years to 15 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with confirmed diagnosis of rheumatic fever based on laboratory investigations.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

laboratory investigations (ASOt , ESR . CRP)

Time Frame: One year from October 2017 to september 2018

laboratory investigations that measure the inflammation process will be used and the target that the ASOt not increase 1/400

Secondary Outcomes

  • clinical measures(One year from October 2017 to september 2018)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Patricia reda hanna

Resident doctor

Assiut University

Study Sites (1)

Loading locations...

Similar Trials